Lyophilized recombinant human brain natriuretic peptide for chronic heart failure: Effects on cardiac function and inflammation

Table 4 Comparison of the quality of life between the two groups (mean ± SD, score)

Group	Physical strength		Emotions		Society		Economy
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Control group (n = 51)	34.48 ± 3.56	22.72 ± 2.93a	17.42 ± 2.14	7.12 ± 1.81a	12.23 ± 2.54	7.84 ± 1.52a	10.25 ± 1.23	6.52 ± 1.28a
Observation group (n = 51)	34.35 ± 3.41	17.15 ± 2.64a	17.63 ± 2.25	5.83 ± 1.24a	12.62 ± 2.45	5.41 ± 1.24a	10.36 ± 1.25	4.25 ± 0.57a
t value	0.188	10.086	0.483	4.199	0.789	8.847	0.448	11.570
P value	0.851	< 0.001	0.630	< 0.001	0.432	< 0.001	0.655	< 0.001

^aP < 0.05 vs pretreatment.